Documente Academic
Documente Profesional
Documente Cultură
Background
Breast Cancer :
comes from ducts or lobes
29 % of all new malignant disease
incidents: 170 000 cases per year
Indonesia: second highest incidence after cervix ca
patients usually come at an advanced stage
Risk factors
Sex,
Age
Family history
Prior breast cancer ~ contralateral breast
Benign breast disease :Proliferative histologic pattern +
Atypical hyperplasia
Endogenous endocrine factors
Age at menarche < 13 y.o.
Ag at menopause > 55 y.o.
Parity
Age at first full-term pregnancy > 35 y.o.
Exogenous hormone use :Oral contraceptive
Exposure to ionizing radiation between age 13 and 30
Obesity & Alcohol consumption
Classification of breast cancer
Non invasive carcinoma
Non invasive ductal carcinoma
Lobular carcinoma in situ
Invasive carcinoma
Invasive ductal carcinoma
Special types
Paget’s disease
Histological grading
Gx : can not be assessed
G1 : low grade
G2 : intermediate grade
G3 : high grade
Examination
Recommended
Breast US
X ray
Whole abdomen US
Optional
Bone scan
CT scan
Therapeutic modalities
Operation
Radiation
Chemotherapy
hormonal therapy
Molecular targeting therapy
Bilateral breast cancer
incidence : 4–20% in patients with primary
operable breast cancer
The risk factors associated with bilateral
occurrence are:
familial or hereditary breast cancer,
young age at primary breast cancer diagnosis,
lobular invasive carcinoma,
multicentricity
radiation exposure
In bilateral breast cancer, it is important to
know whether contralateral breast lesion is
metastatic or second primary not easy
Chaudary et al proposed criteria for the
diagnosis of second primary breast cancer in
1984
Chaudary criteria :
there must be in situ change in the
contralateral tumor
the tumor in the second breast is histologically
different from the cancer in the first breast
the degree of histological differentiation of the
tumor in the second breast is distinctly greater
than that of the lesion in the first breast
there is no evidence of local, regional,or
distant metastases from the cancer in the
ipsilateral breast
Therapy
The best management of patients with
bilateral breast cancer (CBC) is still not
known.
Traditionally, most clinicians have
approached bilateral breast cancer more
aggressively than unilateral disease
Bilateral / unilateral mastectomy / BCT
Bilateral / unilateral radiotherapy
Chemotherapy
Hormonal therapy
Prognosis
No abnormalities of
the heart and lungs
Conclusion :
no bone metastases
Histopathology (incisional biopsy 20/1/12)
IHK (7/2/12)
Treatment
Bilateral modified radical mastectomy
Surgery
Histopathology (operatif,20/1/12)